Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
iX Biopharma
Singapore
C
51-100 Employees
2000
Key takeaway
iX Biopharma Ltd develops innovative therapies aimed at enhancing the quality of life for patients with pain and chronic diseases. They utilize their patented WaferiX sublingual drug delivery technology to provide unique formulations, including NAD+, which may be relevant to peptide therapeutics in terms of advanced delivery methods.
Reference
Core business
iX Biopharma
Matralix
Singapore
C
- Employees
-
Key takeaway
Matralix is focused on transforming the encapsulation industry, offering innovative solutions for the development and manufacturing of novel biopharmaceuticals and cosmetics. Their expertise in encapsulation directly supports the discovery and scalable production of peptide therapeutics.
Reference
Core business
Matralix | Singapore | Encapsulation | Oral Drug Delivery | Cosmetics
We develop encapsulation solutions for pharma cosmetics, food and fine chemicals industries.
CellVec Pte Ltd
Singapore
C
11-50 Employees
2018
Key takeaway
CellVec is a certified GMP gene therapy CDMO that specializes in providing custom viral vectors for pre-clinical and clinical applications. They utilize a lentivirus-based Vector Platform to enhance the production of viral vectors and develop innovative gene transfer technologies, which could be highly relevant for advancing peptide therapeutics.
Reference
Core business
CellVec | Innovation for Patient Benefit
A certified GMP gene therapy CDMO that is a specialist provider of custom viral vectors for pre-clinical and clinical applications
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Tessa Therapeutics
Singapore
C
101-250 Employees
2001
Key takeaway
Tessa Therapeutics is a biotechnology company that is developing innovative allogeneic cell therapies for cancer, including a unique CD30-CAR EBVST platform that targets various cancers. Their focus on next-generation immunotherapies highlights the potential for transformative treatments in the field of cancer therapeutics.
Reference
Core business
Tessa Therapeutics | Cancer Immunotherapy Treatments
Cure cancers with our innovative and widely accessible immunotherapies. Tessa Therapeutics is a clinical-stage biotechnology company focused on the development of autologous and allogeneic cell therapies for a broad range of cancers.
Macrogen Asia Pacific Pte. Ltd.
Singapore
C
11-50 Employees
-
Key takeaway
Macrogen APAC is a leading provider of genomics services, offering advanced techniques such as Next Generation Sequencing and Capillary Electrophoresis Sequencing. Their expertise in precision medicine and clinical diagnostics positions them as key players in the field of genomic research and applications.
Reference
Core business
Precision Medicine, Genomics Services Singapore - Macrogen Asia Pacific Pte Ltd
Research services include Next Generation Sequencing, Capillary Electrophoresis Sequencing, Microarrays, Transgenic mice, Oligonucleotide synthesis. Clinical services include hereditary cancer testing, somatic cancer panels, carrier testing, NIPT screening, clinical WGS and clinical WES.
MiRXES
Singapore
C
11-50 Employees
2014
Key takeaway
MiRXES is a pioneering RNA technology company focused on developing and commercializing non-invasive blood tests for the early detection of cancer and other diseases. Their innovative approach utilizes microRNA biomarkers to enhance diagnostic solutions, making them accessible for timely intervention.
Reference
Core business
Homepage - MiRXES
A NEW DAWN in disease early interception Featured Our Science & Pipeline At MiRXES, we harness the power of RNA to deliver early, actionable and personalized diagnoses across the care continuum to improve and save lives. Prevention is better than cure. With early detection, mitigating risk factors and implementing prevention strategies, most cancer deaths can … Homepage Read More »
Taiho Pharma Asia Pacific Pte. Ltd.
Singapore
C
11-50 Employees
2011
Key takeaway
Taiho Pharma Asia Pacific is dedicated to enhancing the lives of cancer patients through the introduction of high-quality anticancer drugs. Their commitment to specialty pharmaceuticals underscores their focus on patient care and the broader impact of their therapeutic innovations.
Reference
Core business
TAIHO PHARMA ASIA PACIFIC
TAIHO PHARMA ASIA PACIFIC focus as we pioneer and produce our line of specialty pharmaceuticals is not the drug industry, but the benefit of the people we serve.
Advanced Cell Therapy and Research Institute Singapore
Singapore
C
51-100 Employees
2020
Key takeaway
ACTRIS is focused on advancing cellular-based therapeutics, including immunotherapy and regenerative medicine, through discovery, process development, and manufacturing. Their commitment to quality compliance and regulatory facilitation positions them as a key player in the development and delivery of innovative therapies.
Reference
Service
Business Development Services | Cell Therapy Manufacturing and Process Development
Clearbridge Medical Group
Singapore
C
11-50 Employees
-
Key takeaway
The company is focused on developing efficient solutions for early disease detection and personalized chronic disease management, which may include innovative approaches relevant to peptide therapeutics.
Reference
Product
BioTech Corp - Bio Nexus | Clearbridge Medical Group
PrintBioTech Corp - Bio Nexus
jMedtech
Singapore
C
- Employees
-
Key takeaway
jMedtech specializes in developing innovative medical coatings and catheter components, positioning itself as a key player in advancing healthcare technologies. Their commitment to transforming medical device endeavors aligns with their mission to provide cutting-edge solutions that enhance patient care.
Reference
Core business
jMedtech- delivering medical coatings to medical device manufacturers, products include hydrophilic
jMedtech aims at delivering best-in-class medical coatings and one-stop coating solutions to medical device manufacturers worldwide, our products include hydrophilic paint and friction test equipment.
Technologies which have been searched by others and may be interesting for you:
When exploring the peptide therapeutics industry in Singapore, several key considerations come into play. Singapore has established itself as a biotech hub, offering a robust regulatory framework that supports innovation while ensuring safety and efficacy. The Health Sciences Authority (HSA) oversees the approval process for peptide-based therapies, which is crucial for companies aiming to bring products to market. Additionally, the country’s strong intellectual property protections encourage research and development, making it an attractive location for investment. Challenges include navigating stringent regulations and securing clinical trial approvals, which can be time-consuming. However, opportunities abound, particularly in collaboration with research institutions and leveraging Singapore's strategic location in Asia for market access. The competitive landscape features a mix of established multinational corporations and dynamic startups, fostering an ecosystem rich in innovation. Environmental concerns also play a role, as companies are increasingly expected to adopt sustainable practices in their manufacturing processes. Overall, understanding these factors is essential for anyone looking to engage with the peptide therapeutics industry in Singapore, as the global market for peptide therapeutics continues to expand, driven by advancements in personalized medicine and targeted therapies.
Some interesting numbers and facts about your company results for Peptide Therapeutics
| Country with most fitting companies | Singapore |
| Amount of fitting manufacturers | 45 |
| Amount of suitable service providers | 31 |
| Average amount of employees | 51-100 |
| Oldest suiting company | 2000 |
| Youngest suiting company | 2020 |
Some interesting questions that has been asked about the results you have just received for Peptide Therapeutics
What are related technologies to Peptide Therapeutics?
Based on our calculations related technologies to Peptide Therapeutics are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on Peptide Therapeutics?
The most represented industries which are working in Peptide Therapeutics are Biotechnology, Pharmaceuticals, Healthcare, IT, Software and Services, Other
How does ensun find these Peptide Therapeutics Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.